Thanks once again to everyone who tunes in here. Will be spotty posting the next week as I am trying to work in a little holiday vacation. Madoff Scam Hits Harvard Medical School Grants and affiliate Beth Israel Medical Center Genentech Embraces Cloud Computing subscription service from...
This is an interesting view on how employees viewed their CEOs from the poll. Amgen shown on the “Naughty List” while Genentech faired at the top on the “Nice CEO” list. Also of interest was to see Goldman Sachs on the nice list, a surprise of sorts. BD Employee-reviews...
Genentech is a large biotech pharmaceutical company in San Francisco and the the largest company to subscribe to the web based “cloud” products from Google, however Google is not able to offer a 100% solution and departments will be able to choose between using some of the traditional products from Microsoft...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-21-2008
Filed under:
Filed under: Technology, Other Items of Interest, Microsoft/Windows News, microsoft, Pharma, Biotech, Google, software, Heatlhcare, Genentech, Office, collaboration, document sharing, Oracle, Cloud Computing
The trial is for women who have the HER2 gene and have already received treatments, details listed below. BD The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an...
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-26-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
All over healthcare the big fish, little fish story is either taking place or actions are in the making for offers. There certainly are a number of big Pharma companies with money to foot the bill, that is if the Biotech companies see it fit to consider the options. One problem as indicated in...
Right now according to the Wall Street Journal, patients who have enjoyed an open relationship are worried that this could all change under management from Roche. Is bigger always better? Recently in the news Genentech is not happy with the offer and may hold out for more. Anyone that...
More business action with big pharma and the biotech industry, although Roche and Genentech already are invested together and have worked on conjunction on research projects. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of all outstanding shares. Roche...